Add listing
    0
    Add listing

    Fimmcyte AG Verified listing

    • Swiss Biotech Association
      Member

    FimmCyte is developing disease modifying therapies for chronic diseases through the direct elimination of diseased cells. FimmCyte has a pipeline of assets two of which are about to begin IND enabling studies, one for endometriosis and the second for organ fibrosis.

    Location
    Canton
    Facts & figures
    • Type of organization
      Private company
    • Year of foundation
      2022
    • Number of employees in Switzerland
      1-9
    Key business

    You may also be interested in